| Colorectal Cancer |
0 |
1 |
| Biliary Disease |
0 |
0.49 |
| Colitis |
0 |
0.35 |
| Diarrhea |
0 |
0.35 |
| Gastroenteritis |
0 |
0.35 |
| Remission |
0 |
0.35 |
| Liver Disease |
0 |
0.33 |
| Ulcerative Colitis |
0 |
0.29 |
| Inflammatory Bowel Disease |
0 |
0.27 |
| Primary Sclerosing Cholangitis |
0 |
0.25 |
| Cholangitis |
0 |
0.24 |
| Colonoscopy |
0 |
0.24 |
| Endoscopy |
0 |
0.24 |
| Liver |
0 |
0.24 |
| Gastroesophageal Reflux Disease |
0 |
0.21 |
| GLP-1 Receptor Agonist |
0 |
0.2 |
| Otolaryngology |
0 |
0.18 |
| Autoimmune Hepatitis |
0 |
0.17 |
| Colorectal Cancer Screening |
0 |
0.17 |
| Endoscopic Imaging |
0 |
0.17 |
| Bowel Preparation |
0 |
0.14 |
| Autoimmune Pancreatitis |
0 |
0.12 |
| Biologic Therapy |
0 |
0.12 |
| Biopsy |
0 |
0.12 |
| Cancer |
0 |
0.12 |
| Cholecystectomy |
0 |
0.12 |
| Cholecystitis |
0 |
0.12 |
| Clinical Guidelines |
0 |
0.12 |
| Cough |
0 |
0.12 |
| Crohn Disease |
0 |
0.12 |
| Diverticulitis |
0 |
0.12 |
| Esophagus |
0 |
0.12 |
| Europe |
0 |
0.12 |
| Fertility |
0 |
0.12 |
| Gallbladder |
0 |
0.12 |
| Hepatitis |
0 |
0.12 |
| Hepatitis A |
0 |
0.12 |
| Immunopathogenesis |
0 |
0.12 |
| Larynx |
0 |
0.12 |
| Medical Innovations |
0 |
0.12 |
| Meta-Analysis |
0 |
0.12 |
| Pancreatitis |
0 |
0.12 |
| Receptors |
0 |
0.12 |
| Statins |
0 |
0.12 |
| Ultrasonography |
0 |
0.12 |
| Abdominal Infection |
0 |
0.07 |
| Barrett Esophagus |
0 |
0.07 |
| Celiac Disease |
0 |
0.07 |
| Diverticular Disease |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Helicobacter Pylori |
0 |
0.07 |
| Lipids Management |
0 |
0.07 |
| Type 2 Diabetes Mellitus |
0 |
0.07 |